300 North Capital’s Seagen Inc. Common Stock SGEN Stock Holding History

300 North Capital’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-22,299	Closed	-$789K	–	92
2015 Q1	$789K	Sell	22,299 -3,881	-15%	-$132K	0.17%	97
2014 Q4	$841K	Buy	26,180 +27	+0.1%	+$941	0.19%	91
2014 Q3	$972K	Sell	26,153 -27,900	-52%	-$1.1M	0.26%	93
2014 Q2	$2.07M	Buy	54,053 +2,290	+4%	+$86.6K	0.51%	72
2014 Q1	$2.36M	Buy	51,763 +3,190	+7%	+$153K	0.61%	71
2013 Q4	$1.94M	Sell	48,573 -1,929	-4%	-$78.7K	0.54%	76
2013 Q3	$2.21M	Buy	50,502 +23,802	+89%	+$991K	0.52%	76
2013 Q2	$840K	Buy	+26,700	New	+$931K	0.33%	86

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

300 North Capital's SGEN Position: Q2 2015 in Review

300 North Capital sold out of Seagen Inc. Common Stock (SGEN) in Q2 2015, closing a stake of 22,299 shares — an estimated $789K sold.

300 North Capital first reported a position in SGEN in Q2 2013 and held it in 8 quarters. The position peaked at $2.36M in Q1 2014. 220 funds tracked by Wall St. Rank hold SGEN as of Q2 2015.

300 North Capital reported no remaining Seagen Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
300 North Capital sold 22,299 Seagen Inc. Common Stock shares in Q2 2015, an estimated $789K.
300 North Capital first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 8 quarters.
300 North Capital's Seagen Inc. Common Stock position peaked at $2.36M in Q1 2014.
220 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2015.

Based on 300 North Capital's 13F filing for Q2 2015, filed 30 Jul 2015.